This study identified predictors of appointment adherence and examined its impacts on improvements in metabolic risk factors in a free city-wide cardiovascular disease prevention program in Seoul, South Korea. Data of 8251 citizens with metabolic syndrome were used. Appointment adherers were defined as having 70% or higher adherence rates, that is, 3 or more visits. Of the 8251 citizens, 17.6% were appointment adherers. Appointment adherers were significantly more likely to be older, low-income earners, nonsmokers, and nonobese than appointment nonadherers. Moreover, appointment adherers, compared with nonadherers, showed significant improvements in waist circumference, systolic blood pressure, and high-density lipoprotein cholesterol, but not in fasting glucose and triglycerides. Designing strategies for increasing appointment adherence to a free city-wide cardiovascular disease prevention program is essential to improve health outcomes, especially targeting population groups with young age, high-income, current smoking, or obesity.
GalassiAReynoldsKHeJ.Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119: 812-819.
2.
SundstromJRiserusUBybergLZetheliusBLithellHLindL.Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006;332:878-882.
3.
GrundySMCleemanJIDanielsSR, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
4.
ChooJYoonSJRyuH, et al. The Seoul Metropolitan Lifestyle Intervention Program and metabolic syndrome risk: a retrospective database study. Int J Environ Res Public Health. 2016;13:667.
5.
World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
6.
NwabuoCCDySMWeeksKYoungJH.Factors associated with appointment non-adherence among African-Americans with severe, poorly controlled hypertension. PLoS One. 2014; 9:e103090.
7.
PatnodeCDEvansCVSengerCARedmondNLinJS.Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force. Vol HHSA-290-2012-00015-I. Agency for Healthcare Research and Quality; 2017.
8.
ButrynMLWebbVWaddenTA.Behavioral treatment of obesity. Psychiatr Clin North Am. 2011;34:841-859.
9.
BergMBSafrenSAMimiagaMJGrassoCBoswellSMayerKH.Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care. 2005;17:902-907.
10.
ColubiMMPerez-EliasMJEliasL, et al; SEAD Study Group. Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death. HIV Clin Trials. 2012;13:289-295.
11.
NutiLALawleyMTurkcanA, et al. No-shows to primary care appointments: subsequent acute care utilization among diabetic patients. BMC Health Serv Res. 2012;12:304.
12.
BaileyJEWanJYTangJGhaniMACushmanWC.Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010;25:495-503.
13.
ShinYKLeeSOParkHI.Evaluation of Analytical Performance of Lipid Pro Point-of-Care Analyzers. The Catholic University, Korea; 2010.
14.
JeongTDLeeWChunSMinWK.Performance evaluation of the LABGEO PT10 point-of-care chemistry analyzer. J Lab Med Qual Assur. 2013;35:70-80.
15.
Cholesterol Reference Method Laboratory Network. The Accuracy of LDX System. University of Washington; 2010.
SusinNde Melo BoffRLudwigMWB, et al. Predictors of adherence in a prevention program for patients with metabolic syndrome. J Health Psychol. 2016;21:2156-2167.
18.
DeversMCCampbellSSimmonsD.Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease. BMJ Open Diabetes Res Care. 2016;4:e000195.
19.
AnthonyNMolokwuJAlozieOMagallanesD.Implementation of a text message to improve adherence to clinic and social service appointments. J Int Assoc Provid AIDS Care. 2019;18:2325958219870166.
20.
KardasPLewekPMatyjaszczykM.Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
21.
GaalemaDESavagePDRengoJL, et al. Patient characteristics predictive of cardiac rehabilitation adherence. J Cardiopulm Rehabil Prev. 2017;37:103.
22.
ShermanBWLynchWD. The association of smoking with medical treatment adherence in the workforce of a large employer. Patient Prefer Adher. 2014;8:477-486.
23.
BradshawAJHorwathCCKatzerLGrayA.Non-dieting group interventions for overweight and obese women: what predicts non-completion and does completion improve outcomes?Public Health Nutr. 2010;13:1622-1628.
24.
HsiaJRodaboughRRosalMC, et al. Compliance with national cholesterol education program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia: the Women’s Health Initiative. Am J Med. 2002;113:384-392.
KimSChinM. Changes in the time spent on housework of married couples: analysis of Korea time use survey from 2004 to 2014. J Korean Home Manag Assoc.2016;34:65-84.
27.
ZazpeIEstruchRToledoE, et al. Predictors of adherence to a Mediterranean-type diet in the PREDIMED trial. Eur J Nutr. 2010;49:91-99.
ColleyRCHillsAPO’Moore-SullivanTMHickmanIJPrinsJBByrneNM.Variability in adherence to an unsupervised exercise prescription in obese women. Int J Obes (Lond). 2008;32:837-844.
30.
GillRSuperkoHRMcCarthyMM, et al. Cardiovascular risk factor reduction in first responders resulting from an individualized lifestyle and blood test program: a randomized controlled trial. J Occup Med. 2019;61:183-189.
31.
LiJYeobKTanK, et al. Tackling cardiometabolic risk in the Asia Pacific region. Am J Prev Cardiol. 2020;4: 100096.
32.
TsushitaKHoslerASMiuraK, et al. Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J Atheroscler Thromb. 2018;25:308-322.
